These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36226248)

  • 1. Overexpression of LncRNA MNX1-AS1/PPFIA4 Activates AKT/HIF-1
    Sun Q; Gui Z; Zhao Z; Xu W; Zhu J; Gao C; Zhao W; Hu H
    J Oncol; 2022; 2022():8303409. PubMed ID: 36226248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
    Lv Y; Li H; Li F; Liu P; Zhao X
    Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer.
    Cheng Y; Pan Y; Pan Y; Wang O
    Cancer Manag Res; 2019; 11():803-812. PubMed ID: 30697072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC-Activated LncRNA
    Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R
    Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer.
    Liu G; Guo X; Zhang Y; Liu Y; Li D; Tang G; Cui S
    Onco Targets Ther; 2019; 12():3129-3138. PubMed ID: 31118668
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA MNX1-AS1 Contributes to Laryngeal Squamous Cell Carcinoma Growth and Migration by Regulating mir-744-5p/bcl9/β-Catenin Axis.
    Ma B; Ren G; Xu J; Yin C; Shi Y
    Cell Transplant; 2021; 30():9636897211005682. PubMed ID: 33821684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MNX1-AS1 contributes to lung adenocarcinoma progression by targeting the miR-34a/SIRT1 axis.
    Liu G; Zhang Y; Zhang X; Liu Y; Xu Y; Cui S; Li G; Wang J
    Am J Transl Res; 2022; 14(7):4977-4989. PubMed ID: 35958481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation.
    Wu Y; Wang Y; Yao H; Li H; Meng F; Li Q; Lin X; Liu L
    J Exp Clin Cancer Res; 2022 Dec; 41(1):337. PubMed ID: 36476366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA MNX1-AS1 promotes migration and invasion of esophageal squamous cell carcinoma by upregulating IGF2.
    Zheng DN; Zhang CJ; Sun GP
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6179-6185. PubMed ID: 31364117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
    Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
    Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer.
    Lv D; Wang Y; Li S; Shao X; Jin Q
    Mol Biotechnol; 2023 Jan; 65(1):72-83. PubMed ID: 35819746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA ILF3-AS1 Promotes the Progression of Colon Adenocarcinoma Cells Through the miR-619-5p/CAMK1D Axis.
    Liu W; Li S
    Onco Targets Ther; 2021; 14():1861-1872. PubMed ID: 33737811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway.
    Liu X; Yang Q; Yan J; Zhang X; Zheng M
    J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
    Yang R; Wang L; Han M
    J Cell Biochem; 2019 May; 120(5):7222-7228. PubMed ID: 30506837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA ZEB1-AS1 promotes colon adenocarcinoma malignant progression via miR-455-3p/PAK2 axis.
    Ni X; Ding Y; Yuan H; Shao J; Yan Y; Guo R; Luan W; Xu M
    Cell Prolif; 2020 Jan; 53(1):e12723. PubMed ID: 31828845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.
    Ma JX; Yang YL; He XY; Pan XM; Wang Z; Qian YW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4756-4762. PubMed ID: 31210302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.
    Li F; Chen Q; Xue H; Zhang L; Wang K; Shen F
    Cell Death Dis; 2020 Oct; 11(10):894. PubMed ID: 33093444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3.
    Li J; Li Q; Li D; Shen Z; Zhang K; Bi Z; Li Y
    Front Oncol; 2020; 10():1108. PubMed ID: 32754442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.